DAVID N GILL Insider Trading Transactions
Get free email notifications about insider trading for DAVID N GILL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID N GILL. DAVID N GILL is Senior Vice President and CFO in CTI MOLECULAR IMAGING INC ($CTMI) and in STRATA Skin Sciences, Inc. ($MELA) and Director in STRATA Skin Sciences, Inc. ($MELA) and Director in HISTOGENICS CORP ($HSGX) and Director in CEMPRA, INC. ($CEMP) and Director in Evolus, Inc. ($EOLS) and Chief Financial Officer in EndoChoice Holdings, Inc. ($GI) and President and CFO in EndoChoice Holdings, Inc. ($GI) and Director in Strongbridge Biopharma plc ($SBBP) and Director in Y-mAbs Therapeutics, Inc. ($YMAB).
Latest Insider Trading Transactions of DAVID N GILL
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTMI, GI, EOLS, MLNT, HSGX, MELA, SBBP, YMAB
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Option Exercise | A | 37.53 | 16,000 | 600,480 | 16,000 | |
May 18 2021 | SBBP | Strongbridge Bioph ... | GILL DAVID N | Director | Grant | A | 0.00 | 40,000 | 0 | 95,821 | 55.8 K to 95.8 K (+71.66 %) |
Feb 09 2021 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Grant | A | 0.00 | 19,313 | 0 | 24,313 | 5 K to 24.3 K (+386.26 %) |
Jan 20 2021 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Option Exercise | M | 11.16 | 2,000 | 22,320 | 24,000 | |
Jan 20 2021 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Sell | S | 46.52 | 2,000 | 93,045 | 0 | 2 K to 0 (-100.00 %) |
Jan 20 2021 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Buy | M | 11.16 | 2,000 | 22,320 | 2,000 | 0 to 2 K |
Nov 20 2020 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Option Exercise | M | 11.16 | 2,000 | 22,320 | 26,000 | |
Nov 20 2020 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Sell | S | 45.77 | 2,000 | 91,530 | 0 | 2 K to 0 (-100.00 %) |
Nov 20 2020 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Buy | M | 11.16 | 2,000 | 22,320 | 2,000 | 0 to 2 K |
Nov 05 2020 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Option Exercise | M | 11.16 | 4,000 | 44,640 | 28,000 | |
Nov 05 2020 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Sell | S | 45.00 | 4,000 | 180,000 | 0 | 4 K to 0 (-100.00 %) |
Nov 05 2020 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Buy | M | 11.16 | 4,000 | 44,640 | 4,000 | 0 to 4 K |
Sep 28 2020 | SBBP | Strongbridge Bioph ... | GILL DAVID N | Director | Buy | P | 2.13 | 8,000 | 17,040 | 74,896 | 66.9 K to 74.9 K (+11.96 %) |
Sep 04 2020 | SBBP | Strongbridge Bioph ... | GILL DAVID N | Director | Payment of Exercise | F | 3.61 | 23,104 | 83,405 | 66,896 | 90 K to 66.9 K (-25.67 %) |
Jun 24 2020 | YMAB | Y-mAbs Therapeutic ... | GILL DAVID N | Director | Option Exercise | A | 48.67 | 16,000 | 778,720 | 16,000 | |
May 15 2020 | SBBP | Strongbridge Bioph ... | GILL DAVID N | Director | Grant | A | 0.00 | 40,000 | 0 | 90,000 | 50 K to 90 K (+80.00 %) |
May 15 2020 | SBBP | Strongbridge Bioph ... | GILL DAVID N | Director | Grant | A | 0.00 | 40,000 | 0 | 90,000 | 50 K to 90 K (+80.00 %) |
Jan 24 2020 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
Nov 26 2019 | MELA | STRATA Skin Scienc ... | GILL DAVID N | Grant | A | 0.00 | 18,293 | 0 | 64,694 | 46.4 K to 64.7 K (+39.42 %) | |
Jun 14 2019 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | P | 13.65 | 2,000 | 27,300 | 5,000 | 3 K to 5 K (+66.67 %) |
Jun 12 2019 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Jan 25 2019 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | A | 16.19 | 14,500 | 234,755 | 14,500 | |
Dec 17 2018 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | P | 12.77 | 3,000 | 38,300 | 3,000 | 0 to 3 K |
Dec 17 2018 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Buy | P | 12.77 | 3,000 | 38,300 | 3,000 | 0 to 3 K |
Jun 19 2018 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 2.97 | 25,000 | 74,250 | 25,000 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 7.45 | 9,100 | 67,795 | 9,100 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 7.45 | 9,100 | 67,795 | 9,100 | |
Jun 14 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
Jun 11 2018 | MELA | STRATA Skin Scienc ... | GILL DAVID N | Director | Option Exercise | A | 2.07 | 26,570 | 55,000 | 26,570 | |
May 30 2018 | MLNT | MELINTA THERAPEUTI ... | GILL DAVID N | Director | Buy | P | 6.09 | 5,000 | 30,450 | 6,000 | 1,000 to 6 K (+500.00 %) |
Apr 26 2018 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | A | 8.01 | 22,696 | 181,795 | 22,696 | |
Aug 17 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.81 | 3,000 | 5,439 | 14,000 | 11 K to 14 K (+27.27 %) |
Jun 14 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 1.70 | 25,000 | 42,500 | 25,000 | |
May 17 2017 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.68 | 3,000 | 5,040 | 11,000 | 8 K to 11 K (+37.50 %) |
Jan 05 2017 | CEMP | CEMPRA, INC. | GILL DAVID N | Director | Option Exercise | A | 3.00 | 15,000 | 45,000 | 15,000 | |
Jan 04 2017 | CEMP | CEMPRA, INC. | GILL DAVID N | Director | Buy | P | 2.94 | 5,000 | 14,720 | 5,000 | 0 to 5 K |
Dec 19 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.65 | 3,000 | 4,950 | 8,000 | 5 K to 8 K (+60.00 %) |
Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.92 | 5,000 | 9,600 | 5,000 | 0 to 5 K |
Nov 23 2016 | GI | EndoChoice Holding ... | GILL DAVID N | President and CFO | Option Exercise | D | 16.01 | 53,825 | 861,738 | 0 | |
Nov 23 2016 | GI | EndoChoice Holding ... | GILL DAVID N | President and CFO | Option Exercise | D | 5.31 | 32,230 | 171,141 | 0 | |
Nov 23 2016 | GI | EndoChoice Holding ... | GILL DAVID N | President and CFO | Sell | D | 8.00 | 38,585 | 308,680 | 0 | 38.6 K to 0 (-100.00 %) |
Nov 23 2016 | GI | EndoChoice Holding ... | GILL DAVID N | President and CFO | Sell | D | 8.00 | 125,445 | 1,003,560 | 0 | 125.4 K to 0 (-100.00 %) |
Mar 31 2016 | GI | EndoChoice Holding ... | GILL DAVID N | President and CFO | Option Exercise | A | 5.31 | 32,230 | 171,141 | 32,230 | |
Mar 31 2016 | GI | EndoChoice Holding ... | GILL DAVID N | President and CFO | Grant | A | 0.00 | 14,826 | 0 | 137,405 | 122.6 K to 137.4 K (+12.10 %) |
Mar 10 2016 | GI | EndoChoice Holding ... | GILL DAVID N | Chief Financial Off ... | Buy | P | 4.70 | 2,000 | 9,400 | 25,130 | 23.1 K to 25.1 K (+8.65 %) |
Mar 07 2016 | GI | EndoChoice Holding ... | GILL DAVID N | Chief Financial Off ... | Buy | P | 4.77 | 5,000 | 23,850 | 23,130 | 18.1 K to 23.1 K (+27.58 %) |
Jan 05 2016 | CEMP | CEMPRA, INC. | GILL DAVID N | Director | Option Exercise | A | 31.13 | 15,000 | 466,950 | 15,000 | |
Aug 17 2015 | GI | EndoChoice Holding ... | GILL DAVID N | Chief Financial Off ... | Option Exercise | A | 16.01 | 53,825 | 861,738 | 53,825 | |
Aug 17 2015 | GI | EndoChoice Holding ... | GILL DAVID N | Chief Financial Off ... | Grant | A | 0.00 | 53,825 | 0 | 133,049 | 79.2 K to 133 K (+67.94 %) |
Jun 26 2015 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 6.86 | 6,800 | 46,648 | 6,800 | |
May 06 2005 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Option Exercise | D | 0.00 | 242,547 | 0 | 0 | |
May 06 2005 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Sell | U | 20.50 | 3,200 | 65,600 | 0 | 3.2 K to 0 (-100.00 %) |
May 06 2005 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Sell | U | 20.50 | 3,200 | 65,600 | 0 | 3.2 K to 0 (-100.00 %) |
May 06 2005 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Sell | U | 20.50 | 93,000 | 1,906,500 | 0 | 93 K to 0 (-100.00 %) |
Jan 19 2005 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Option Exercise | M | 4.69 | 9,700 | 45,469 | 171,800 | |
Jan 19 2005 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Buy | M | 4.69 | 9,700 | 45,469 | 93,000 | 83.3 K to 93 K (+11.64 %) |
Oct 19 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Option Exercise | M | 4.69 | 10,501 | 49,223 | 181,500 | |
Oct 19 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Buy | M | 4.69 | 10,501 | 49,223 | 83,300 | 72.8 K to 83.3 K (+14.42 %) |
Oct 18 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Option Exercise | M | 4.69 | 12,799 | 59,995 | 192,001 | |
Oct 18 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Buy | M | 4.69 | 12,799 | 59,995 | 72,799 | 60 K to 72.8 K (+21.33 %) |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Option Exercise | A | 5.56 | 12,800 | 71,200 | 12,800 | |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Option Exercise | D | 5.56 | 12,800 | 71,200 | 51,200 | |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Option Exercise | A | 4.69 | 51,200 | 240,000 | 51,200 | |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Option Exercise | D | 4.69 | 51,200 | 240,000 | 204,800 | |
Oct 12 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
Jun 04 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Sell | S | 13.72 | 15,000 | 205,800 | 0 | 15 K to 0 (-100.00 %) |
May 13 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Sell | S | 14.07 | 10,000 | 140,700 | 15,000 | 25 K to 15 K (-40.00 %) |
Mar 03 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Sell | S | 16.49 | 14,000 | 230,889 | 25,000 | 39 K to 25 K (-35.90 %) |
Feb 19 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Sell | S | 17.67 | 16,000 | 282,720 | 39,000 | 55 K to 39 K (-29.09 %) |
Feb 12 2004 | CTMI | CTI MOLECULAR IMAG ... | GILL DAVID N | Senior Vice Preside ... | Option Exercise | A | 15.05 | 19,547 | 294,182 | 19,547 |
Page: 1